Evidence map›Paper›PMID 30927007›Full record

ArticleTransactions of the Royal Society of Tropical Medicine and Hygiene2019

Serological evidence for a decline in malaria transmission following major scale-up of control efforts in a setting selected for Plasmodium vivax and Plasmodium falciparum malaria elimination in Babile district, Oromia, Ethiopia.

Migbaru Keffale, Girma Shumie, Sinknesh Wolde Behaksra, Wakweya Chali, Lotus L van den Hoogen, Elifaged Hailemeskel, Daniel Mekonnen, Menberework Chanyalew, Demekech Damte, Tiruwork Fanta and 12 more

Open access · hybridAbstract read
In one paragraph

Article in Transactions of the Royal Society of Tropical Medicine and Hygiene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Serology reveals comparable patterns in the transmission intensities ofFrontiers in cellular and infection microbiology · 2025
    Article
  2. Article
  3. Using Serological Markers for the Surveillance ofPathogens (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Article
  6. Naturally acquired antibody response toFrontiers in cellular and infection microbiology · 2023
    Article
  7. Article
  8. Article
  9. Antibodies Against theFrontiers in cellular and infection microbiology · 2021
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 3 countries.

Migbaru KeffaleMalaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, POBox 1005, Addis Ababa, Ethiopia.
Girma ShumieMalaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, POBox 1005, Addis Ababa, Ethiopia.
Sinknesh Wolde BehaksraMalaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, POBox 1005, Addis Ababa, Ethiopia.
Wakweya ChaliMalaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, POBox 1005, Addis Ababa, Ethiopia.
Lotus L van den HoogenDepartment of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK.
Elifaged HailemeskelMalaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, POBox 1005, Addis Ababa, Ethiopia.
Daniel MekonnenMalaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, POBox 1005, Addis Ababa, Ethiopia.
Menberework ChanyalewMalaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, POBox 1005, Addis Ababa, Ethiopia.
Demekech DamteMalaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, POBox 1005, Addis Ababa, Ethiopia.
Tiruwork FantaMalaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, POBox 1005, Addis Ababa, Ethiopia.
Temesgen AshineMalaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, POBox 1005, Addis Ababa, Ethiopia.
Sagni ChaliMalaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, POBox 1005, Addis Ababa, Ethiopia.
Kevin K A TettehDepartment of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK.
Dereje Dillu BirhanuFederal Ministry of Health, Addis Ababa, Ethiopia.
Taye T BalchaMalaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, POBox 1005, Addis Ababa, Ethiopia.
Abraham AseffaMalaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, POBox 1005, Addis Ababa, Ethiopia.
Chris DrakeleyDepartment of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK.
Tesfaye S TessemaInstitute of Biotechnology, Addis Ababa University, POBox 1176, Addis Ababa, Ethiopia.
Haileeyesus AdamuInstitute of Biotechnology, Addis Ababa University, POBox 1176, Addis Ababa, Ethiopia.
Teun BousemaDepartment of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK.
Endalamaw GadisaMalaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, POBox 1005, Addis Ababa, Ethiopia.
Fitsum G TadesseMalaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, POBox 1005, Addis Ababa, Ethiopia.
Armauer Hansen Research Institute · ETLondon School of Hygiene & Tropical Medicine · GBAddis Ababa University · ETRadboud University Nijmegen · NLFederal Ministry of Health · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFollowing successful malaria control during the last decade, Ethiopia instituted a stepwise malaria elimination strategy in selected low-transmission areas.

methodsCross-sectional surveys were conducted in Babile district, Oromia, Ethiopia from July to November 2017 to evaluate malaria infection status using microscopy and nested polymerase chain reaction (nPCR) and serological markers of exposure targeting Plasmodium falciparum and Plasmodium vivax apical membrane antigen-1 (AMA-1).

resultsParasite prevalence was 1.2% (14/1135) and 5.1% (58/1143) for P. falciparum and 0.4% (5/1135) and 3.6% (41/1143) for P. vivax by microscopy and nPCR, respectively. Antibody prevalence was associated with current infection by nPCR for both P. falciparum (p<0.001) and P. vivax (p=0.014) and showed an age-dependent increase (p<0.001, for both species). Seroconversion curves indicated a decline in malaria exposure 15 y prior to sampling for P. falciparum and 11.5 y prior to sampling for P. vivax, broadly following malaria incidence data from district health offices, with higher antibody titres in adults than children for both species.

conclusionsMalaria transmission declined substantially in the region with continuing heterogeneous but measurable local transmission, arguing in favour of continued and tailored control efforts to accelerate the progress towards elimination efforts.

Indexed as

AdolescentAdultChildChild, PreschoolCross-Sectional StudiesEthiopiaFemaleHumansMalaria, FalciparumMalaria, VivaxMaleMiddle AgedPlasmodium falciparumPlasmodium vivaxPrevalenceSeroepidemiologic Studiescurrent infectionmalaria eliminationmetrics of transmissionserology

Identifiers

PMID30927007
PMCPMC6580689
OpenAlexW2925512365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.